BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 6994782)

  • 1. Comparison of guanfacine and clonidine as antihypertensive agents.
    Jäättelä A
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):67S-70S. PubMed ID: 6994782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive effect of guanfacine: a double-blind cross-over trial compared with clonidine.
    Distler A; Kirch W; Lüth B
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):49S-53S. PubMed ID: 6994778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical experience with guanfacine in long-term treatment of hypertension. Part II: adverse reactions to guanfacine.
    Jerie P
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):157S-164S. PubMed ID: 6994770
    [No Abstract]   [Full Text] [Related]  

  • 4. [A new antihypertensive agent used in a clinical setting].
    Wetzels E; Raschig A; Kaiser HJ
    Med Klin; 1980 Sep; 75(19):688-92. PubMed ID: 7001207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypotensive effect of guanfacine in essential hypertension: a comparison with clonidine.
    Lauro R; Reda G; Spallone L; Anguissola AB
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):81S-82S. PubMed ID: 6994784
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative study of two antihypertensive agents: guanfacine and guanethidine.
    Szám I; Kállay K
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):85S-87S. PubMed ID: 6994786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of guanfacine and clonidine in essential hypertension: a single-blind crossover study.
    Miach PJ; Louis WJ
    Med J Aust; 1980 Oct; 2(7):395-6. PubMed ID: 7005630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of single and multiple doses of guanfacine in essential hypertension.
    Zamboulis C; Reid JL
    Clin Pharmacol Ther; 1980 Dec; 28(6):715-21. PubMed ID: 7002428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of antihypertensive activity and tolerability of guanfacine and methyldopa.
    Malini PL; Strocchi E; Ambrosioni E; Magnani B
    Int J Clin Pharmacol Res; 1983; 3(1):35-9. PubMed ID: 6384071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonidine and guanfacine in hypertension.
    Jain AK; Hiremath A; Michael R; Ryan JR; McMahon FG
    Clin Pharmacol Ther; 1985 Mar; 37(3):271-6. PubMed ID: 3882307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical dose-response studies with guanfacine (BS 100-141), a new antihypertensive agent.
    MacCarthy P; Isaac P; Frost G; Freeman A; Stokes G
    Clin Exp Pharmacol Physiol; 1978; 5(2):187-90. PubMed ID: 348364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of once-daily guanfacine and twice-a-day methyldopa in the treatment of mild to moderate hypertension.
    Farooki MS; Farsky K; Bouchard S; Lalonde Y; Brookman S
    Clin Ther; 1985; 7(2):199-204. PubMed ID: 3886142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guanfacine: a new centrally-acting antihypertensive agent.
    Beevers DG; Bloxham CA; Walker JM
    Pharmatherapeutica; 1981; 2(8):513-6. PubMed ID: 7019931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of guanfacine versus clonidine for efficacy, safety and occurrence of withdrawal syndrome in step-2 treatment of mild to moderate essential hypertension.
    Wilson MF; Haring O; Lewin A; Bedsole G; Stepansky W; Fillingim J; Hall D; Roginsky M; McMahon FG; Jagger P
    Am J Cardiol; 1986 Mar; 57(9):43E-49E. PubMed ID: 3513530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term efficacy and tolerance of the antihypertensive agent guanfacine.
    Jerie P; Lasance A
    Int J Clin Pharmacol Ther Toxicol; 1984 Mar; 22(3):170-4. PubMed ID: 6370876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guanfacine in the treatment of hypertension: two years' experience with low dose monotherapy.
    Jerie P; Lasance A
    Int J Clin Pharmacol Ther Toxicol; 1981 Jun; 19(6):279-87. PubMed ID: 7030975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacology of centrally acting antihypertensive agents.
    Weber MA
    J Clin Pharmacol; 1989 Jul; 29(7):598-602. PubMed ID: 2668350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of long-term treatment of essential hypertension with guanfacine.
    Higuchi M; Overlack A; Stumpe KO
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):61S-64S. PubMed ID: 6994780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term treatment of hypertension with guanfacine alone and in combination therapy.
    Seedat YK
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):65S-66S. PubMed ID: 6994781
    [No Abstract]   [Full Text] [Related]  

  • 20. Guanfacine: effects of long-term treatment and withdrawal.
    Reid JL; Zamboulis C; Hamilton CA
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):183S-188S. PubMed ID: 6994774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.